Peroxisomal disorders include a complex spectrum of diseases, characterized by a high heterogeneity from both the clinical and the biochemical points of view. Specific assays are required for the study of peroxisome metabolism. Among these,
pipecolic acid evaluation is considered as a supplementary test. We have established the diagnostic role of
pipecolic acid in 30 patients affected by a peroxisomal defect (5 Zellweger syndromes, 10 Infantile Refsum diseases, 1
neonatal adrenoleukodystrophy, 6 patients affected by a peroxisomal biogenesis disorder with unclassified phenotype, 1 case of
rhizomelic chondrodysplasia punctata (RCDP), 2
acyl-CoA oxidase deficiencies, 2 bifunctional
enzyme deficiencies, 2 Refsum diseases, and 1 beta-oxidation deficiency).
Pipecolic acid was increased in all generalized
peroxisomal disorders, while normal
pipecolic acid with abnormal very long chain
fatty acid concentrations was strong evidence for a single peroxisomal
enzyme deficiency. Unexpectedly, hyperpipecolic acidaemia was found also in a child affected by RCDP and in two patients with
Refsum disease. In six patients the suggestion of a
peroxisomal disorder was raised by the fortuitous finding of a
pipecolic acid peak in
amino acid chromatography, routinely performed as a general metabolic screening. For all patients,
pipecolic acid proved to be a useful parameter in the biochemical classification of
peroxisomal disorders.